Sanon Biotech: Wholly-owned subsidiary Meishan Huilong obtains drug production license.

Sina Finance reported on March 30th that Shengnuo Biotechnology announced that its wholly-owned subsidiary Meishan Huilong Pharmaceutical Technology Co., Ltd. recently received the "Drug Production License" issued by the Sichuan Provincial Drug Administration. The company's name is Meishan Huilong Pharmaceutical Technology Co., Ltd., with license number Chuang 20260663, valid until March 25, 2031. This is the first time that Meishan Huilong has obtained a "Drug Production License," indicating that its raw materials are officially qualified for compliant production, which is conducive to the company maintaining stable production capacity, improving core competitiveness, and playing a positive role in promoting the company's future stable development.